Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome
Background: Lennox-Gastaut syndrome (LGS) is a severe form of childhood-onset epilepsy associated with serious injuries due to frequent and severe seizures. Of the antiepileptic drugs (AEDs) approved for LGS, clobazam is a more recent market entrant, having been approved in October 2011. Recent AED...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2017-01-01
|
| Series: | Journal of Market Access & Health Policy |
| Assuntos: | |
| Acceso en liña: | http://dx.doi.org/10.1080/20016689.2017.1318691 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|